MRS7292
Appearance
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C20H18ClN5O4S |
Molar mass | 459.91 g·mol−1 |
3D model (JSmol) | |
| |
|
MRS7292 is an experimental drug which acts as both a selective agonist of the adenosine A3 receptor with moderate affinity, and also a dopamine reuptake inhibitor, showing that these disparate mechanisms of action can both be produced in the same molecule.[1][2]
See also
[edit]References
[edit]- ^ Tosh DK, Janowsky A, Eshleman AJ, Warnick E, Gao ZG, Chen Z, et al. (April 2017). "Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters". Journal of Medicinal Chemistry. 60 (7): 3109–3123. doi:10.1021/acs.jmedchem.7b00141. PMC 5501184. PMID 28319392.
- ^ Tosh DK, Salmaso V, Rao H, Campbell R, Bitant A, Gao ZG, et al. (October 2020). "Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists". ACS Medicinal Chemistry Letters. 11 (10): 1935–1941. doi:10.1021/acsmedchemlett.9b00637. PMC 7549272. PMID 33062176.